Steven Cohen’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TGTX
Steven Cohen's TGTX Position: Q3 2026 in Review
Steven Cohen increased its TG Therapeutics (TGTX) stake by 70% in Q3 2026, buying an estimated $10.1M and bringing the position to 451,269 shares worth $25.2M. The position accounts for 0.03% of the portfolio, ranked #785.
Steven Cohen first reported a position in TGTX in Q1 2018 and has held it in 14 quarters since. The position peaked at $25.8M in Q2 2025. 451 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.
- Steven Cohen held 451,269 shares of TG Therapeutics worth $25.2M as of Q3 2026.
- Steven Cohen bought 186,306 TG Therapeutics shares in Q3 2026, an estimated $10.1M.
- TG Therapeutics made up 0.03% of Steven Cohen's portfolio in Q3 2026, its #785 holding.
- Steven Cohen first reported a position in TG Therapeutics in Q1 2018 and has held it in 14 quarters since.
- Steven Cohen's TG Therapeutics position peaked at $25.8M in Q2 2025.
- 451 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.